
Procter & Gamble's CFO Andre Schulten reported that fiscal year 2024 marked the sixth consecutive year of at least 4% organic sales growth, demonstrating resilience through various economic conditions. However, market challenges intensified in fiscal year 2025, leading to increased volatility. Through March, organic sales are up 2%, aligning with the company's fiscal year guidance provided in the Q3 earnings release, with growth spread across 9 of 10 categories.
Procter & Gamble (NYSE:PG) reported strong historical performance, achieving its sixth consecutive year of 4% or greater organic sales growth in fiscal year 2024, demonstrating resilience across diverse economic conditions including the COVID-19 pandemic, supply chain disruptions, inflationary pressures, and consumption slowdowns. However, the company acknowledged increased market volatility in the consumer and retail environment for fiscal year 2025. Despite these challenges, organic sales through March are up 2%, aligning with the guidance provided in its Q3 earnings release. This current growth is notably broad-based, with nine out of ten product categories either growing or maintaining their organic sales levels, indicating a degree of underlying strength across its portfolio even as overall growth moderates from previous highs.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment